SYRINX Bioanalytics is a CRO focusing on the bioanalysis and immunogenicity testing of biological drugs, vaccines, biomarkers and small molecules providing GLP compliant laboratory services using state-of-the-art immunological, chromatographic and cell based methods.
Over 20 years of experience in GLP – involvement in numerous drug development projects from preclinical to globally marketed products in e.g. Europe, Northern America and Japan.
Immunogenicity testing
Following latest guidelines and white papers SYRINX is providing novel immunogenicity assay designs and methods for immunogenicity testing. Try out and see flash animation of various screening assay designs.
Immunoassay techniques
SYRINX is offering to its customers a large variety of immunoassay techniques. Victor V, Envision Xcite, Biacore T100 GxP, Winspectral/Wizard, Gyrolab xP and MSD Sector Imager 2400 (Meso Scale) instruments are enabling DELFIA, ELISA, AlphaScreen/AlphaLISA, surface plasmon resonance (SPR), RIA, Gyros CD microlaboratory and electrochemiluminescence (ECL) techniques.
News and events
SYRINX attended "Immunogenicity of Biologics 2010" 9th-10th of February 2010 in Prague, Czech Republic.
SYRINX has acquired Gyrolab xP instrument enabling Gyros CD microlaboratory assays.
SYRINX will attend "Immunogenicity for Biologics" 28th-29th of September 2010 in Brussels, Belgium.
SYRINX will attend "Biosimilars Conference" 5th-7th of October 2010 in London, UK.
SYRINX will attend "International Drug Discovery Science and Technology" 23th-26th of October 2010 in Beijing, China.